Table of contents
Volume 87, Issue 10
Published online 4 November 2002 (1057-1194)
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics
Review
Role of genetic polymorphisms in tumour angiogenesis FREE
S P Balasubramanian, N J Brown and M W R Reed
Br J Cancer 87: 1057-1065; doi:10.1038/sj.bjc.6600625
Clinical
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer FREE
C Bokemeyer, K Oechsle, J T Hartmann, P Schöffski, N Schleucher, B Metzner, J Schleicher and L Kanz
Br J Cancer 87: 1066-1071; doi:10.1038/sj.bjc.6600629
Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer FREE
P A Vasey, H Roché, D Bisset, C Terret, L Vernillet, A Riva, C Ramazeilles, N Azli, S B Kaye and C J Twelves
Br J Cancer 87: 1072-1078; doi:10.1038/sj.bjc.6600626
A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients FREE
T Bachelot, F Gomez, P Biron, I Ray-Coquard, P Soler-Michel, I Philip, J P Guastalla, P Rebattu, A Dumortier, J P Droz and J Y Blay
Br J Cancer 87: 1079-1085; doi:10.1038/sj.bjc.6600631
Choroid plexus tumours FREE
J E A Wolff, M Sajedi, R Brant, M J Coppes and R M Egeler
Br J Cancer 87: 1086-1091; doi:10.1038/sj.bjc.6600609
Nephrotoxicity in survivors of Wilms' tumours in the North of England FREE
S Bailey, A Roberts, C Brock, L Price, A W Craft, R Kilkarni, R E J Lee, A W Skillen and R Skinner
Br J Cancer 87: 1092-1098; doi:10.1038/sj.bjc.6600608
Social problems in oncology FREE
E P Wright, M A Kiely, P Lynch, A Cull and P J Selby
Br J Cancer 87: 1099-1104; doi:10.1038/sj.bjc.6600642
Molecular and Cellular Pathology
Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence FREE
D Coradini, C Pellizzaro, S Veneroni, L Ventura and M G Daidone
Br J Cancer 87: 1105-1111; doi:10.1038/sj.bjc.6600556
Lung tumour markers in oncology practice: a study of TPA and CA125 FREE
G Buccheri and D Ferrigno
Br J Cancer 87: 1112-1118; doi:10.1038/sj.bjc.6600577
Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells FREE
S Junnikkala, J Hakulinen, H Jarva, T Manuelian, L Bjørge, R Bützow, P F Zipfel and S Meri
Br J Cancer 87: 1119-1127; doi:10.1038/sj.bjc.6600614
Elevated c-Src is linked to altered cell–matrix adhesion rather than proliferation in KM12C human colorectal cancer cells FREE
R J Jones, E Avizienyte, A W Wyke, D W Owens, V G Brunton and M C Frame
Br J Cancer 87: 1128-1135; doi:10.1038/sj.bjc.6600594
Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas FREE
R Kikuchi, T Noguchi, S Takeno, Y Funada, H Moriyama and Y Uchida
Br J Cancer 87: 1136-1139; doi:10.1038/sj.bjc.6600579
Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma FREE
M Suzuoki, M Miyamoto, K Kato, K Hiraoka, T Oshikiri, Y Nakakubo, A Fukunaga, T Shichinohe, T Shinohara, T Itoh, S Kondo and H Katoh
Br J Cancer 87: 1140-1144; doi:10.1038/sj.bjc.6600619
Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications FREE
G Ferrandina, L Lauriola, G F Zannoni, M G Distefano, F Legge, V Salutari, M Gessi, N Maggiano, G Scambia and F O Ranelletti
Br J Cancer 87: 1145-1152; doi:10.1038/sj.bjc.6600578
Genetics and Genomics
Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites FREE
C Sakakura, A Hagiwara, M Nakanishi, K Shimomura, T Takagi, R Yasuoka, Y Fujita, T Abe, Y Ichikawa, S Takahashi, T Ishikawa, I Nishizuka, T Morita, H Shimada, Y Okazaki, Y Hayashizaki and H Yamagishi
Br J Cancer 87: 1153-1161; doi:10.1038/sj.bjc.6600580
Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours FREE
H Özda
, S J Batley, A Försti, N G Iyer, Y Daigo, J Boutell, M J Arends, B A J Ponder, T Kouzarides and C Caldas
Br J Cancer 87: 1162-1165; doi:10.1038/sj.bjc.6600554
Experimental Therapeutics
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects FREE
K Dredge, J B Marriott, C D Macdonald, H-W Man, R Chen, G W Muller, D Stirling and A G Dalgleish
Br J Cancer 87: 1166-1172; doi:10.1038/sj.bjc.6600607
Regulation of a rat VL30 element in human breast cancer cells in hypoxia and anoxia: role of HIF-1 FREE
K Ameri, B Burke, C E Lewis and A L Harris
Br J Cancer 87: 1173-1181; doi:10.1038/sj.bjc.6600576
Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis FREE
O Stoeltzing, S A Ahmad, W Liu, M F McCarty, A A Parikh, F Fan, N Reinmuth, C D Bucana and L M Ellis
Br J Cancer 87: 1182-1187; doi:10.1038/sj.bjc.6600598
Anisomycin activates JNK and sensitises DU 145 prostate carcinoma cells to Fas mediated apoptosis FREE
J F Curtin and T G Cotter
Br J Cancer 87: 1188-1194; doi:10.1038/sj.bjc.6600612
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
